Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

GlobeNewswireOct 31 08:00 ET

Promising Results of CD388 Lead to Buy Rating for Cidara Therapeutics

TipRanksOct 22 06:25 ET · Ratings

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswireOct 4 16:30 ET

Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August

Seeking AlphaOct 4 14:02 ET

Cidara Therapeutics Announces Two Presentations On Innovative Drug-Fc Conjugate, CD388, At The 2024 OPTIONS XII For The Control Of Influenza Conference

BenzingaSep 25 08:05 ET

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

GlobeNewswireSep 23 08:00 ET